Menu
Home
Forums
Forums
Quick Links
Search Forums
Recent Posts
job listings
catering
whistleblower info
legal help
advertise on CP
submit press release
Menu
Log in
Sign up
Search titles only
Posted by Member:
Separate names with a comma.
Newer Than:
Search this thread only
Search this forum only
Display results as threads
More...
Useful Searches
Recent Posts
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Abbott
>
Abbott Diabetes Care
>
Reply to Thread
Name:
Verification:
Answer the above question:
(
CustomImgCaptcha
By
Surrey Forum
)
Message:
<p>[QUOTE="Anonymous, post: 3339987"]<b>Poor Leadership at Abbott Diabetes Care</b></p><p><br /></p><p>In the past 8 months, there were layoffs made at both the Alameda, CA and Witney, UK facilities, encompassing a wide array of departments. The most recent one happened in the second week of January 2010. </p><p><br /></p><p>One of the biggest challenges facing ADC is that its technology is not at par with the competition. For example, its continuous glucose monitoring system, Navigator, is yet to make money and the current version is still undergoing a myriad of design changes. Just take a look at the FDA website and see how many changes have been made to the Navigator since it was approved. Likewise, the FreeStyle test strips use a chemistry that is the subject of an FDA and Health Canada public health notification, since the GDH-PQQ enzyme which ADC uses can cause highly elevated glucose readings. This is all occasioned by a very poor R&D leadership, whose VPs lack vision and market acumen. Rather than focusing on fixing issues that address complaint trends, the technical operations team are not trailblazers, but simply follow Bayer and Lifescan. </p><p><br /></p><p>The Regulatory Affairs and Clinical Affairs leadership is also very weak, with a current leader that never had any clinical trials background and no regulatory experience in IVDs. In just one year, senior regulatory professionals and an RA manager have left that department, dismayed at the favoritism and poor management fromt he top. The Quality Systems leadership is also equally pathetic. The environment is very fissiparous, with leaders being hired from within and promoted from one department to another, having no background at all in their new responsibilities. Such promotions are occasioned by cronyism and connections more than skill set competencies.</p><p><br /></p><p>Mr. White needs to seriously take a look at this division and bring in some McKinsey folks to assess its deficiencies. Should anyone from Abbott Corporate read this, please just respond and provide an e-mail and I will be more than happy to contact them directly to discuss my perspective.[/QUOTE]</p><p><br /></p>
[QUOTE="Anonymous, post: 3339987"][b]Poor Leadership at Abbott Diabetes Care[/b] In the past 8 months, there were layoffs made at both the Alameda, CA and Witney, UK facilities, encompassing a wide array of departments. The most recent one happened in the second week of January 2010. One of the biggest challenges facing ADC is that its technology is not at par with the competition. For example, its continuous glucose monitoring system, Navigator, is yet to make money and the current version is still undergoing a myriad of design changes. Just take a look at the FDA website and see how many changes have been made to the Navigator since it was approved. Likewise, the FreeStyle test strips use a chemistry that is the subject of an FDA and Health Canada public health notification, since the GDH-PQQ enzyme which ADC uses can cause highly elevated glucose readings. This is all occasioned by a very poor R&D leadership, whose VPs lack vision and market acumen. Rather than focusing on fixing issues that address complaint trends, the technical operations team are not trailblazers, but simply follow Bayer and Lifescan. The Regulatory Affairs and Clinical Affairs leadership is also very weak, with a current leader that never had any clinical trials background and no regulatory experience in IVDs. In just one year, senior regulatory professionals and an RA manager have left that department, dismayed at the favoritism and poor management fromt he top. The Quality Systems leadership is also equally pathetic. The environment is very fissiparous, with leaders being hired from within and promoted from one department to another, having no background at all in their new responsibilities. Such promotions are occasioned by cronyism and connections more than skill set competencies. Mr. White needs to seriously take a look at this division and bring in some McKinsey folks to assess its deficiencies. Should anyone from Abbott Corporate read this, please just respond and provide an e-mail and I will be more than happy to contact them directly to discuss my perspective.[/QUOTE]
Your name or email address:
Do you already have an account?
No, create an account now.
Yes, my password is:
Forgot your password?
Stay logged in
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Abbott
>
Abbott Diabetes Care
>
Cafepharma Message Boards | Pharma Sales, Device Sales, Lab Sales
Home
Forums
>
Pharma/Biotech Companies
>
Abbott
>
Abbott Diabetes Care
>